| __timestamp | Alnylam Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 21584000 |
| Thursday, January 1, 2015 | 41097000 | 28006000 |
| Friday, January 1, 2016 | 47159000 | 39623000 |
| Sunday, January 1, 2017 | 76545000 | 43758000 |
| Monday, January 1, 2018 | 73106000 | 58930000 |
| Tuesday, January 1, 2019 | 194688000 | 83845000 |
| Wednesday, January 1, 2020 | 414801000 | 76028000 |
| Friday, January 1, 2021 | 704143000 | 145114000 |
| Saturday, January 1, 2022 | 868601000 | 194954000 |
| Sunday, January 1, 2023 | 1517886000 | 248148000 |
| Monday, January 1, 2024 | 1924873000 |
Data in motion
In the dynamic world of biotechnology, Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Alnylam's gross profit surged by an impressive 2,900%, reflecting its robust growth trajectory and innovative breakthroughs. In contrast, Veracyte's gross profit increased by approximately 1,050%, showcasing its steady expansion in the diagnostic space.
Alnylam's journey is marked by a significant leap in 2023, where its gross profit reached a peak, underscoring its strategic advancements in RNA interference therapeutics. This growth is a testament to its successful product launches and expanding market presence.
Veracyte, while not as explosive, has consistently grown, doubling its gross profit from 2020 to 2023. This steady climb highlights its commitment to enhancing diagnostic solutions and expanding its test offerings.
Both companies exemplify the diverse strategies within the biotech sector, each contributing uniquely to healthcare innovation.
Gross Profit Trends Compared: Novo Nordisk A/S vs Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Veracyte, Inc.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Viatris Inc. or Veracyte, Inc.
Gross Profit Analysis: Comparing Dr. Reddy's Laboratories Limited and Veracyte, Inc.
Gross Profit Analysis: Comparing Veracyte, Inc. and Travere Therapeutics, Inc.
Gross Profit Analysis: Comparing Veracyte, Inc. and MiMedx Group, Inc.